IP Library Assignment 056574/0576
Patent Assignment
Reel/Frame 056574/0576

Assignment of Assignor's Interest

Recorded: 2021-06-17 Pages: 3
Assignors
BAE, SUK CHUL
Executed: 2021-04-16
LEE, JUNG WON
Executed: 2021-04-16
LEE, YOU SOUB
Executed: 2021-04-16
Assignee
RUN-X CORPORATION
1, CHUNGDAE-RO, SEOWON-GU, CHUNGCHEONGBUK-DO, CHEONGJU-SI, 28644, KOREA, REPUBLIC OF
Covered Property (1)
PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 PROTEIN AND CDK4 INHIBITOR OR mTOR INHIBITOR COTREATMENT FOR PREVENTION OR TREATMENT OF CANCER
Application: 17/239,433 →
Publication: US 2021/0330742
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Apr 20, 2023
From: RUN X CORPORATION
To: GENECRAFT INC.
Reel/Frame 063397/0450 →